BiotechTube
Home/Pulmatrix/Robert W. Clarke
RW

Robert W. Clarke

Chief Operating Officer/Head of R&D

Pulmatrix

Therapeutic Areas

RespiratoryNeurological

Pulmatrix Pipeline

DrugIndicationPhase
PUR3100Acute MigrainePhase 2
PUR1800Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD)Phase 1b/2a
PUR1900Allergic Bronchopulmonary Aspergillosis (ABPA) in Asthma / Cystic FibrosisPhase 2
PUR0200Chronic Obstructive Pulmonary Disease (COPD)Preclinical

Leadership Team at Pulmatrix

TR
Ted Raad
Chief Executive Officer
MW
Margaret Wasilewski
Chief Medical Officer
JP
John P. Hamill
Chief Financial Officer
View full Pulmatrix profile